JUVÉDERM® VOLUMA® With Lidocaine for Correction of Temple Hollowing in Chinese Population

PHASE3CompletedINTERVENTIONAL
Enrollment

168

Participants

Timeline

Start Date

July 20, 2021

Primary Completion Date

November 22, 2023

Study Completion Date

November 22, 2023

Conditions
Temple Hollowing
Interventions
DEVICE

JUVÉDERM® VOLUMA® with Lidocaine

JUVÉDERM® VOLUMA® with Lidocaine injectable gel

Trial Locations (8)

100029

China-Japan Friendship Hospital /ID# 241680, Beijing

100730

Beijing Hospital /ID# 233582, Beijing

102206

Peking University International Hospital /ID# 242166, Beijing

200011

Shanghai Ninth People's Hospital,Shanghai Jiaotong University School of Medicine /ID# 233571, Shanghai

200233

Shanghai Sixth People's Hospital /ID# 233568, Shanghai

210008

Nanjing Drum Tower Hospital /ID# 233607, Nanjing

210009

Zhongda Hospital Southeast University /ID# 233604, Nanjing

430022

Union Hospital Tongji Medical College Huazhong University of Science and Technol /ID# 233602, Wuhan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Allergan

INDUSTRY